Help Us Protect Access to Sexual and Reproductive Health Care Today!
This patient fact sheet compares different birth control choices in a colorful and easy to read chart. The methods are organized alphabetically. The sheet includes essential information about each method, how to use, impact on bleeding/menstruation, along with common side effects. Ideal for health centers, doctor’s offices, and school clinics.
The pill user guide explains the basics of how to use the birth control pill.
A tool for health care providers who want to check a patient’s medical eligibility for various forms of contraception as they relate to absolute and relative contraindications.
This clinical guide explains how health care providers can Quick Start contraception.
Payment Assistance Programs: DepoProvera (Progestin Injection) Pfizer Patient Assistance Program: Provides injected progestin, intramuscular for office administration and subcutaneous for home administration. IUDs (Intrauterine Devices) ARCH Foundation: Patient Assistance Program for Mirena, Kyleena, and Skyla IUDs Liletta Patient Savings Program ParaGard Patient Assistance Program Oral Contraceptive Pills 340B Drug Pricing Program: Offers birth control pills…
This poster compares birth control choices based on efficacy, cost, side effects, and other patient-focused factors.
Explains the basics of how to use the progestin-only pill.
This sheet answers common patient questions about continuous use of birth control (especially the pill, patch, and ring), skipping periods and explains how to do so safely.
Some people prefer to take hormonal birth control without estrogen. This fact sheet highlights the progestin-only options that are available. Spanish: Updated 2024 Reading Grade Level (Flesch-Kincaid Grade Level): 6.2 Sources: CDC – Injectables – US SPR – Reproductive Health. Centers for Disease Control and Prevention. https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/injectables.html. Published May 20, 2021. Accessed…
This presentation is a teaching tool was created for a clinical audience to demonstrate how to use WHO/CDC categories for eligibility, how to counsel patients about contraceptive efficacy for successful prevention of unintended pregnancy and to address systems practices which can affect contraceptive initiation and continuation rates.